Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Doria

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Immunology|March 1, 1987
Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathyW Barcellini, P L Meroni, D Frasca, et al.
Minerva Ginecologica|July 20, 2004
[Prevention and treatment of congenital toxoplasmosis: organization protocol]A Vimercati, M C Angelici, L De Cosmo, et al.
Molecular Brain|August 21, 2016
Orchestrated activation of mGluR5 and CB1 promotes neuroprotectionEdleusa M L Batista, Juliana G Doria, Talita H Ferreira-Vieira, et al.
Mechanisms of Ageing and Development|April 16, 1998
Cell proliferation and ku protein expression in ageing humansD Frasca, P Barattini, C Goso, et al.
Mechanisms of Ageing and Development|August 28, 1998
Changes in the amount and level of phosphorylation of p56(lck) in PBL from aging humansL Guidi, L Antico, C Bartoloni, et al.
Neurobiology of Disease|August 28, 2014
The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's diseaseJ G Doria, J M de Souza, J N Andrade, et al.
Scandinavian Journal of Gastroenterology|September 28, 1999
Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pyloriA Tricerri, L Guidi, D Frasca, et al.
Neuropsychobiology|November 24, 1999
Neuropeptide Y plasma levels and immunological changes during academic stressL Guidi, A Tricerri, M Vangeli, et al.
British Journal of Pharmacology|March 16, 2013
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's diseaseJ G Doria, F R Silva, J M de Souza, et al.
Transplantation Proceedings|March 27, 2001
Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantationM P Pistillo, P L Tazzari, F Stirpe, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Immunology|March 1, 1987
Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathyW Barcellini, P L Meroni, D Frasca, et al.
Minerva Ginecologica|July 20, 2004
[Prevention and treatment of congenital toxoplasmosis: organization protocol]A Vimercati, M C Angelici, L De Cosmo, et al.
Molecular Brain|August 21, 2016
Orchestrated activation of mGluR5 and CB1 promotes neuroprotectionEdleusa M L Batista, Juliana G Doria, Talita H Ferreira-Vieira, et al.
Mechanisms of Ageing and Development|April 16, 1998
Cell proliferation and ku protein expression in ageing humansD Frasca, P Barattini, C Goso, et al.
Mechanisms of Ageing and Development|August 28, 1998
Changes in the amount and level of phosphorylation of p56(lck) in PBL from aging humansL Guidi, L Antico, C Bartoloni, et al.
Neurobiology of Disease|August 28, 2014
The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's diseaseJ G Doria, J M de Souza, J N Andrade, et al.
Scandinavian Journal of Gastroenterology|September 28, 1999
Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pyloriA Tricerri, L Guidi, D Frasca, et al.
Neuropsychobiology|November 24, 1999
Neuropeptide Y plasma levels and immunological changes during academic stressL Guidi, A Tricerri, M Vangeli, et al.
British Journal of Pharmacology|March 16, 2013
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's diseaseJ G Doria, F R Silva, J M de Souza, et al.
Transplantation Proceedings|March 27, 2001
Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantationM P Pistillo, P L Tazzari, F Stirpe, et al.
Pageof 19